Barbara Guarino

Title: Barbara Guarino: Innovator in Anti-Influenza A Antibodies

Introduction

Barbara Guarino is a notable inventor based in Bellinzona, Switzerland. She has made significant contributions to the field of immunology, particularly in the development of antibodies targeting influenza A viruses. With a total of three patents to her name, her work has the potential to impact public health significantly.

Latest Patents

Among her latest patents is the invention titled "Neutralizing anti-influenza A antibodies and uses thereof." This invention relates to antibodies and binding fragments capable of binding to influenza A virus hemagglutinin. These antibodies are designed to neutralize at least one group 1 subtype and at least one group 2 subtype of the influenza A virus. In one embodiment, the antibodies can bind to and neutralize various influenza A virus group 1 subtypes, including H1, H2, H5, H6, H8, H9, H11, H12, H13, H16, and H17, as well as group 2 subtypes such as H3, H4, H7, H10, H14, and H15.

Career Highlights

Barbara has worked with prominent companies in the biotechnology sector, including Medimmune Limited and Humabs Biomed SA. Her experience in these organizations has allowed her to refine her expertise in antibody development and therapeutic applications.

Collaborations

Throughout her career, Barbara has collaborated with talented individuals such as Ebony Benjamin and Nicole Kallewaard-LeLay. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Barbara Guarino's work in the field of anti-influenza A antibodies showcases her dedication to advancing medical science. Her patents reflect her innovative spirit and commitment to improving public health through targeted therapies.